Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul;31(3):531-551.
doi: 10.1016/j.chc.2022.03.007. Epub 2022 May 11.

Addressing the Treatment and Service Needs of Young Adults with Attention Deficit Hyperactivity Disorder

Affiliations
Review

Addressing the Treatment and Service Needs of Young Adults with Attention Deficit Hyperactivity Disorder

Javier Quintero et al. Child Adolesc Psychiatr Clin N Am. 2022 Jul.

Abstract

The transition from adolescence to adulthood is a complex period in which multiple changes take place (education, work, independent living, and social relations). This stage is especially difficult for adolescents suffering from attention deficit hyperactivity disorder (ADHD), who have to move on from child and adolescent mental health services to adult mental health services. This review analyzes developmental and environmental risk and protective factors as well as critical variables such as executive functioning and self-monitoring that influence the course of ADHD in transitional age youth and guide the priorities for an optimal transition of care. The influence of the COVID-19 pandemic is also discussed. We reflect on the unmet needs for an optimal transition of care and propose practice and policy recommendations to achieve this goal.

Keywords: ADHD; Atomoxetine; Guanfacine; Lisdexamfetamine; Methylphenidate; Nonstimulants; Stimulants; Transition of care.

PubMed Disclaimer

Conflict of interest statement

Disclosure statement and conflict of interest J. Quintero has served as speaker and/or on scientific advisory boards for Takeda, Janssen, and Rubio. A. Rodríguez-Quiroga has received funding from Takeda. F. Mora has served as speaker and/or on scientific advisory boards for Takeda and Janssen. A.L. Rostain has served on the scientific advisory board of Arbor, Supernus, Takeda, and Vallon.

Substances